Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Acne Vulgaris Treatment Market Growth (Status and Outlook) 2022-2028

  • LP 4929736
  • 112 Pages
  • March 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Acne Vulgaris Treatment will have significant change from previous year. According to our (LP Information) latest study, the global Acne Vulgaris Treatment market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Acne Vulgaris Treatment market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Acne Vulgaris Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Acne Vulgaris Treatment market, reaching US$ million by the year 2028. As for the Europe Acne Vulgaris Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Acne Vulgaris Treatment players cover Common Pharma Inc, Cutanea Life Sciences Inc, Dermira Inc, and ELORAC Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Acne Vulgaris Treatment market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

CB-0601

CJM-112

CLS-007

Dapsone

DFD-10

DLX-2323

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Clinic

Hospital

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Common Pharma Inc

Cutanea Life Sciences Inc

Dermira Inc

ELORAC Inc

Ensol Biosciences Inc

Foamix Pharmaceuticals Ltd

Galderma SA

GlaxoSmithKline Plc

Helix BioMedix Inc

Hovione FarmaCiencia SA

Lee's Pharmaceutical Holdings Ltd

LEO Pharma A/S

Novabiotics Ltd

Novan Inc

Novartis AG

Paratek Pharmaceuticals Inc

Pfizer Inc

Phosphagenics Ltd

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Acne Vulgaris Treatment Market Size 2017-2028

2.1.2 Acne Vulgaris Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Acne Vulgaris Treatment Segment by Type

2.2.1 CB-0601

2.2.2 CJM-112

2.2.3 CLS-007

2.2.4 Dapsone

2.2.5 DFD-10

2.2.6 DLX-2323

2.2.7 Others

2.3 Acne Vulgaris Treatment Market Size by Type

2.3.1 Acne Vulgaris Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Acne Vulgaris Treatment Market Size Market Share by Type (2017-2022)

2.4 Acne Vulgaris Treatment Segment by Application

2.4.1 Clinic

2.4.2 Hospital

2.4.3 Others

2.5 Acne Vulgaris Treatment Market Size by Application

2.5.1 Acne Vulgaris Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Acne Vulgaris Treatment Market Size Market Share by Application (2017-2022)

3 Acne Vulgaris Treatment Market Size by Player

3.1 Acne Vulgaris Treatment Market Size Market Share by Players

3.1.1 Global Acne Vulgaris Treatment Revenue by Players (2020-2022)

3.1.2 Global Acne Vulgaris Treatment Revenue Market Share by Players (2020-2022)

3.2 Global Acne Vulgaris Treatment Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Acne Vulgaris Treatment by Regions

4.1 Acne Vulgaris Treatment Market Size by Regions (2017-2022)

4.2 Americas Acne Vulgaris Treatment Market Size Growth (2017-2022)

4.3 APAC Acne Vulgaris Treatment Market Size Growth (2017-2022)

4.4 Europe Acne Vulgaris Treatment Market Size Growth (2017-2022)

4.5 Middle East & Africa Acne Vulgaris Treatment Market Size Growth (2017-2022)

5 Americas

5.1 Americas Acne Vulgaris Treatment Market Size by Country (2017-2022)

5.2 Americas Acne Vulgaris Treatment Market Size by Type (2017-2022)

5.3 Americas Acne Vulgaris Treatment Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Acne Vulgaris Treatment Market Size by Region (2017-2022)

6.2 APAC Acne Vulgaris Treatment Market Size by Type (2017-2022)

6.3 APAC Acne Vulgaris Treatment Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Acne Vulgaris Treatment by Country (2017-2022)

7.2 Europe Acne Vulgaris Treatment Market Size by Type (2017-2022)

7.3 Europe Acne Vulgaris Treatment Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Acne Vulgaris Treatment by Region (2017-2022)

8.2 Middle East & Africa Acne Vulgaris Treatment Market Size by Type (2017-2022)

8.3 Middle East & Africa Acne Vulgaris Treatment Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Acne Vulgaris Treatment Market Forecast

10.1 Global Acne Vulgaris Treatment Forecast by Regions (2023-2028)

10.1.1 Global Acne Vulgaris Treatment Forecast by Regions (2023-2028)

10.1.2 Americas Acne Vulgaris Treatment Forecast

10.1.3 APAC Acne Vulgaris Treatment Forecast

10.1.4 Europe Acne Vulgaris Treatment Forecast

10.1.5 Middle East & Africa Acne Vulgaris Treatment Forecast

10.2 Americas Acne Vulgaris Treatment Forecast by Country (2023-2028)

10.2.1 United States Acne Vulgaris Treatment Market Forecast

10.2.2 Canada Acne Vulgaris Treatment Market Forecast

10.2.3 Mexico Acne Vulgaris Treatment Market Forecast

10.2.4 Brazil Acne Vulgaris Treatment Market Forecast

10.3 APAC Acne Vulgaris Treatment Forecast by Region (2023-2028)

10.3.1 China Acne Vulgaris Treatment Market Forecast

10.3.2 Japan Acne Vulgaris Treatment Market Forecast

10.3.3 Korea Acne Vulgaris Treatment Market Forecast

10.3.4 Southeast Asia Acne Vulgaris Treatment Market Forecast

10.3.5 India Acne Vulgaris Treatment Market Forecast

10.3.6 Australia Acne Vulgaris Treatment Market Forecast

10.4 Europe Acne Vulgaris Treatment Forecast by Country (2023-2028)

10.4.1 Germany Acne Vulgaris Treatment Market Forecast

10.4.2 France Acne Vulgaris Treatment Market Forecast

10.4.3 UK Acne Vulgaris Treatment Market Forecast

10.4.4 Italy Acne Vulgaris Treatment Market Forecast

10.4.5 Russia Acne Vulgaris Treatment Market Forecast

10.5 Middle East & Africa Acne Vulgaris Treatment Forecast by Region (2023-2028)

10.5.1 Egypt Acne Vulgaris Treatment Market Forecast

10.5.2 South Africa Acne Vulgaris Treatment Market Forecast

10.5.3 Israel Acne Vulgaris Treatment Market Forecast

10.5.4 Turkey Acne Vulgaris Treatment Market Forecast

10.5.5 GCC Countries Acne Vulgaris Treatment Market Forecast

10.6 Global Acne Vulgaris Treatment Forecast by Type (2023-2028)

10.7 Global Acne Vulgaris Treatment Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Common Pharma Inc

11.1.1 Common Pharma Inc Company Information

11.1.2 Common Pharma Inc Acne Vulgaris Treatment Product Offered

11.1.3 Common Pharma Inc Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Common Pharma Inc Main Business Overview

11.1.5 Common Pharma Inc Latest Developments

11.2 Cutanea Life Sciences Inc

11.2.1 Cutanea Life Sciences Inc Company Information

11.2.2 Cutanea Life Sciences Inc Acne Vulgaris Treatment Product Offered

11.2.3 Cutanea Life Sciences Inc Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Cutanea Life Sciences Inc Main Business Overview

11.2.5 Cutanea Life Sciences Inc Latest Developments

11.3 Dermira Inc

11.3.1 Dermira Inc Company Information

11.3.2 Dermira Inc Acne Vulgaris Treatment Product Offered

11.3.3 Dermira Inc Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Dermira Inc Main Business Overview

11.3.5 Dermira Inc Latest Developments

11.4 ELORAC Inc

11.4.1 ELORAC Inc Company Information

11.4.2 ELORAC Inc Acne Vulgaris Treatment Product Offered

11.4.3 ELORAC Inc Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 ELORAC Inc Main Business Overview

11.4.5 ELORAC Inc Latest Developments

11.5 Ensol Biosciences Inc

11.5.1 Ensol Biosciences Inc Company Information

11.5.2 Ensol Biosciences Inc Acne Vulgaris Treatment Product Offered

11.5.3 Ensol Biosciences Inc Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Ensol Biosciences Inc Main Business Overview

11.5.5 Ensol Biosciences Inc Latest Developments

11.6 Foamix Pharmaceuticals Ltd

11.6.1 Foamix Pharmaceuticals Ltd Company Information

11.6.2 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Product Offered

11.6.3 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Foamix Pharmaceuticals Ltd Main Business Overview

11.6.5 Foamix Pharmaceuticals Ltd Latest Developments

11.7 Galderma SA

11.7.1 Galderma SA Company Information

11.7.2 Galderma SA Acne Vulgaris Treatment Product Offered

11.7.3 Galderma SA Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Galderma SA Main Business Overview

11.7.5 Galderma SA Latest Developments

11.8 GlaxoSmithKline Plc

11.8.1 GlaxoSmithKline Plc Company Information

11.8.2 GlaxoSmithKline Plc Acne Vulgaris Treatment Product Offered

11.8.3 GlaxoSmithKline Plc Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 GlaxoSmithKline Plc Main Business Overview

11.8.5 GlaxoSmithKline Plc Latest Developments

11.9 Helix BioMedix Inc

11.9.1 Helix BioMedix Inc Company Information

11.9.2 Helix BioMedix Inc Acne Vulgaris Treatment Product Offered

11.9.3 Helix BioMedix Inc Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Helix BioMedix Inc Main Business Overview

11.9.5 Helix BioMedix Inc Latest Developments

11.10 Hovione FarmaCiencia SA

11.10.1 Hovione FarmaCiencia SA Company Information

11.10.2 Hovione FarmaCiencia SA Acne Vulgaris Treatment Product Offered

11.10.3 Hovione FarmaCiencia SA Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Hovione FarmaCiencia SA Main Business Overview

11.10.5 Hovione FarmaCiencia SA Latest Developments

11.11 Lee's Pharmaceutical Holdings Ltd

11.11.1 Lee's Pharmaceutical Holdings Ltd Company Information

11.11.2 Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Product Offered

11.11.3 Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Lee's Pharmaceutical Holdings Ltd Main Business Overview

11.11.5 Lee's Pharmaceutical Holdings Ltd Latest Developments

11.12 LEO Pharma A/S

11.12.1 LEO Pharma A/S Company Information

11.12.2 LEO Pharma A/S Acne Vulgaris Treatment Product Offered

11.12.3 LEO Pharma A/S Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 LEO Pharma A/S Main Business Overview

11.12.5 LEO Pharma A/S Latest Developments

11.13 Novabiotics Ltd

11.13.1 Novabiotics Ltd Company Information

11.13.2 Novabiotics Ltd Acne Vulgaris Treatment Product Offered

11.13.3 Novabiotics Ltd Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Novabiotics Ltd Main Business Overview

11.13.5 Novabiotics Ltd Latest Developments

11.14 Novan Inc

11.14.1 Novan Inc Company Information

11.14.2 Novan Inc Acne Vulgaris Treatment Product Offered

11.14.3 Novan Inc Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Novan Inc Main Business Overview

11.14.5 Novan Inc Latest Developments

11.15 Novartis AG

11.15.1 Novartis AG Company Information

11.15.2 Novartis AG Acne Vulgaris Treatment Product Offered

11.15.3 Novartis AG Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Novartis AG Main Business Overview

11.15.5 Novartis AG Latest Developments

11.16 Paratek Pharmaceuticals Inc

11.16.1 Paratek Pharmaceuticals Inc Company Information

11.16.2 Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Product Offered

11.16.3 Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Paratek Pharmaceuticals Inc Main Business Overview

11.16.5 Paratek Pharmaceuticals Inc Latest Developments

11.17 Pfizer Inc

11.17.1 Pfizer Inc Company Information

11.17.2 Pfizer Inc Acne Vulgaris Treatment Product Offered

11.17.3 Pfizer Inc Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Pfizer Inc Main Business Overview

11.17.5 Pfizer Inc Latest Developments

11.18 Phosphagenics Ltd

11.18.1 Phosphagenics Ltd Company Information

11.18.2 Phosphagenics Ltd Acne Vulgaris Treatment Product Offered

11.18.3 Phosphagenics Ltd Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 Phosphagenics Ltd Main Business Overview

11.18.5 Phosphagenics Ltd Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Acne Vulgaris Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of CB-0601

Table 3. Major Players of CJM-112

Table 4. Major Players of CLS-007

Table 5. Major Players of Dapsone

Table 6. Major Players of DFD-10

Table 7. Major Players of DLX-2323

Table 8. Major Players of Others

Table 9. Acne Vulgaris Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Acne Vulgaris Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 11. Global Acne Vulgaris Treatment Market Size Market Share by Type (2017-2022)

Table 12. Acne Vulgaris Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 13. Global Acne Vulgaris Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 14. Global Acne Vulgaris Treatment Market Size Market Share by Application (2017-2022)

Table 15. Global Acne Vulgaris Treatment Revenue by Players (2020-2022) & ($ Millions)

Table 16. Global Acne Vulgaris Treatment Revenue Market Share by Player (2020-2022)

Table 17. Acne Vulgaris Treatment Key Players Head office and Products Offered

Table 18. Acne Vulgaris Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 19. New Products and Potential Entrants

Table 20. Mergers & Acquisitions, Expansion

Table 21. Global Acne Vulgaris Treatment Market Size by Regions 2017-2022 & ($ Millions)

Table 22. Global Acne Vulgaris Treatment Market Size Market Share by Regions (2017-2022)

Table 23. Americas Acne Vulgaris Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 24. Americas Acne Vulgaris Treatment Market Size Market Share by Country (2017-2022)

Table 25. Americas Acne Vulgaris Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 26. Americas Acne Vulgaris Treatment Market Size Market Share by Type (2017-2022)

Table 27. Americas Acne Vulgaris Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 28. Americas Acne Vulgaris Treatment Market Size Market Share by Application (2017-2022)

Table 29. APAC Acne Vulgaris Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 30. APAC Acne Vulgaris Treatment Market Size Market Share by Region (2017-2022)

Table 31. APAC Acne Vulgaris Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 32. APAC Acne Vulgaris Treatment Market Size Market Share by Type (2017-2022)

Table 33. APAC Acne Vulgaris Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 34. APAC Acne Vulgaris Treatment Market Size Market Share by Application (2017-2022)

Table 35. Europe Acne Vulgaris Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 36. Europe Acne Vulgaris Treatment Market Size Market Share by Country (2017-2022)

Table 37. Europe Acne Vulgaris Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 38. Europe Acne Vulgaris Treatment Market Size Market Share by Type (2017-2022)

Table 39. Europe Acne Vulgaris Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 40. Europe Acne Vulgaris Treatment Market Size Market Share by Application (2017-2022)

Table 41. Middle East & Africa Acne Vulgaris Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Acne Vulgaris Treatment Market Size Market Share by Region (2017-2022)

Table 43. Middle East & Africa Acne Vulgaris Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Acne Vulgaris Treatment Market Size Market Share by Type (2017-2022)

Table 45. Middle East & Africa Acne Vulgaris Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 46. Middle East & Africa Acne Vulgaris Treatment Market Size Market Share by Application (2017-2022)

Table 47. Key Market Drivers & Growth Opportunities of Acne Vulgaris Treatment

Table 48. Key Market Challenges & Risks of Acne Vulgaris Treatment

Table 49. Key Industry Trends of Acne Vulgaris Treatment

Table 50. Global Acne Vulgaris Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 51. Global Acne Vulgaris Treatment Market Size Market Share Forecast by Regions (2023-2028)

Table 52. Global Acne Vulgaris Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 53. Global Acne Vulgaris Treatment Market Size Market Share Forecast by Type (2023-2028)

Table 54. Global Acne Vulgaris Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 55. Global Acne Vulgaris Treatment Market Size Market Share Forecast by Application (2023-2028)

Table 56. Common Pharma Inc Details, Company Type, Acne Vulgaris Treatment Area Served and Its Competitors

Table 57. Common Pharma Inc Acne Vulgaris Treatment Product Offered

Table 58. Common Pharma Inc Acne Vulgaris Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 59. Common Pharma Inc Main Business

Table 60. Common Pharma Inc Latest Developments

Table 61. Cutanea Life Sciences Inc Details, Company Type, Acne Vulgaris Treatment Area Served and Its Competitors

Table 62. Cutanea Life Sciences Inc Acne Vulgaris Treatment Product Offered

Table 63. Cutanea Life Sciences Inc Main Business

Table 64. Cutanea Life Sciences Inc Acne Vulgaris Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Cutanea Life Sciences Inc Latest Developments

Table 66. Dermira Inc Details, Company Type, Acne Vulgaris Treatment Area Served and Its Competitors

Table 67. Dermira Inc Acne Vulgaris Treatment Product Offered

Table 68. Dermira Inc Main Business

Table 69. Dermira Inc Acne Vulgaris Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Dermira Inc Latest Developments

Table 71. ELORAC Inc Details, Company Type, Acne Vulgaris Treatment Area Served and Its Competitors

Table 72. ELORAC Inc Acne Vulgaris Treatment Product Offered

Table 73. ELORAC Inc Main Business

Table 74. ELORAC Inc Acne Vulgaris Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. ELORAC Inc Latest Developments

Table 76. Ensol Biosciences Inc Details, Company Type, Acne Vulgaris Treatment Area Served and Its Competitors

Table 77. Ensol Biosciences Inc Acne Vulgaris Treatment Product Offered

Table 78. Ensol Biosciences Inc Main Business

Table 79. Ensol Biosciences Inc Acne Vulgaris Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Ensol Biosciences Inc Latest Developments

Table 81. Foamix Pharmaceuticals Ltd Details, Company Type, Acne Vulgaris Treatment Area Served and Its Competitors

Table 82. Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Product Offered

Table 83. Foamix Pharmaceuticals Ltd Main Business

Table 84. Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Foamix Pharmaceuticals Ltd Latest Developments

Table 86. Galderma SA Details, Company Type, Acne Vulgaris Treatment Area Served and Its Competitors

Table 87. Galderma SA Acne Vulgaris Treatment Product Offered

Table 88. Galderma SA Main Business

Table 89. Galderma SA Acne Vulgaris Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Galderma SA Latest Developments

Table 91. GlaxoSmithKline Plc Details, Company Type, Acne Vulgaris Treatment Area Served and Its Competitors

Table 92. GlaxoSmithKline Plc Acne Vulgaris Treatment Product Offered

Table 93. GlaxoSmithKline Plc Main Business

Table 94. GlaxoSmithKline Plc Acne Vulgaris Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. GlaxoSmithKline Plc Latest Developments

Table 96. Helix BioMedix Inc Details, Company Type, Acne Vulgaris Treatment Area Served and Its Competitors

Table 97. Helix BioMedix Inc Acne Vulgaris Treatment Product Offered

Table 98. Helix BioMedix Inc Main Business

Table 99. Helix BioMedix Inc Acne Vulgaris Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Helix BioMedix Inc Latest Developments

Table 101. Hovione FarmaCiencia SA Details, Company Type, Acne Vulgaris Treatment Area Served and Its Competitors

Table 102. Hovione FarmaCiencia SA Acne Vulgaris Treatment Product Offered

Table 103. Hovione FarmaCiencia SA Main Business

Table 104. Hovione FarmaCiencia SA Acne Vulgaris Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 105. Hovione FarmaCiencia SA Latest Developments

Table 106. Lee's Pharmaceutical Holdings Ltd Details, Company Type, Acne Vulgaris Treatment Area Served and Its Competitors

Table 107. Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Product Offered

Table 108. Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 109. Lee's Pharmaceutical Holdings Ltd Main Business

Table 110. Lee's Pharmaceutical Holdings Ltd Latest Developments

Table 111. LEO Pharma A/S Details, Company Type, Acne Vulgaris Treatment Area Served and Its Competitors

Table 112. LEO Pharma A/S Acne Vulgaris Treatment Product Offered

Table 113. LEO Pharma A/S Main Business

Table 114. LEO Pharma A/S Acne Vulgaris Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. LEO Pharma A/S Latest Developments

Table 116. Novabiotics Ltd Details, Company Type, Acne Vulgaris Treatment Area Served and Its Competitors

Table 117. Novabiotics Ltd Acne Vulgaris Treatment Product Offered

Table 118. Novabiotics Ltd Main Business

Table 119. Novabiotics Ltd Acne Vulgaris Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 120. Novabiotics Ltd Latest Developments

Table 121. Novan Inc Details, Company Type, Acne Vulgaris Treatment Area Served and Its Competitors

Table 122. Novan Inc Acne Vulgaris Treatment Product Offered

Table 123. Novan Inc Main Business

Table 124. Novan Inc Acne Vulgaris Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 125. Novan Inc Latest Developments

Table 126. Novartis AG Details, Company Type, Acne Vulgaris Treatment Area Served and Its Competitors

Table 127. Novartis AG Acne Vulgaris Treatment Product Offered

Table 128. Novartis AG Main Business

Table 129. Novartis AG Acne Vulgaris Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 130. Novartis AG Latest Developments

Table 131. Paratek Pharmaceuticals Inc Details, Company Type, Acne Vulgaris Treatment Area Served and Its Competitors

Table 132. Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Product Offered

Table 133. Paratek Pharmaceuticals Inc Main Business

Table 134. Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 135. Paratek Pharmaceuticals Inc Latest Developments

Table 136. Pfizer Inc Details, Company Type, Acne Vulgaris Treatment Area Served and Its Competitors

Table 137. Pfizer Inc Acne Vulgaris Treatment Product Offered

Table 138. Pfizer Inc Main Business

Table 139. Pfizer Inc Acne Vulgaris Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 140. Pfizer Inc Latest Developments

Table 141. Phosphagenics Ltd Details, Company Type, Acne Vulgaris Treatment Area Served and Its Competitors

Table 142. Phosphagenics Ltd Acne Vulgaris Treatment Product Offered

Table 143. Phosphagenics Ltd Main Business

Table 144. Phosphagenics Ltd Acne Vulgaris Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 145. Phosphagenics Ltd Latest Developments

List of Figures

Figure 1. Acne Vulgaris Treatment Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Acne Vulgaris Treatment Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Acne Vulgaris Treatment Market Size Market Share by Type in 2021

Figure 7. Acne Vulgaris Treatment in Clinic

Figure 8. Global Acne Vulgaris Treatment Market: Clinic (2017-2022) & ($ Millions)

Figure 9. Acne Vulgaris Treatment in Hospital

Figure 10. Global Acne Vulgaris Treatment Market: Hospital (2017-2022) & ($ Millions)

Figure 11. Acne Vulgaris Treatment in Others

Figure 12. Global Acne Vulgaris Treatment Market: Others (2017-2022) & ($ Millions)

Figure 13. Global Acne Vulgaris Treatment Market Size Market Share by Application in 2021

Figure 14. Global Acne Vulgaris Treatment Revenue Market Share by Player in 2021

Figure 15. Global Acne Vulgaris Treatment Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Acne Vulgaris Treatment Market Size 2017-2022 ($ Millions)

Figure 17. APAC Acne Vulgaris Treatment Market Size 2017-2022 ($ Millions)

Figure 18. Europe Acne Vulgaris Treatment Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Acne Vulgaris Treatment Market Size 2017-2022 ($ Millions)

Figure 20. Americas Acne Vulgaris Treatment Value Market Share by Country in 2021

Figure 21. Americas Acne Vulgaris Treatment Consumption Market Share by Type in 2021

Figure 22. Americas Acne Vulgaris Treatment Market Size Market Share by Application in 2021

Figure 23. United States Acne Vulgaris Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Acne Vulgaris Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Acne Vulgaris Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Acne Vulgaris Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Acne Vulgaris Treatment Market Size Market Share by Region in 2021

Figure 28. APAC Acne Vulgaris Treatment Market Size Market Share by Application in 2021

Figure 29. China Acne Vulgaris Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Acne Vulgaris Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Acne Vulgaris Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Acne Vulgaris Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Acne Vulgaris Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Acne Vulgaris Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Acne Vulgaris Treatment Market Size Market Share by Country in 2021

Figure 36. Europe Acne Vulgaris Treatment Market Size Market Share by Type in 2021

Figure 37. Europe Acne Vulgaris Treatment Market Size Market Share by Application in 2021

Figure 38. Germany Acne Vulgaris Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Acne Vulgaris Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Acne Vulgaris Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Acne Vulgaris Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Acne Vulgaris Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Acne Vulgaris Treatment Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Acne Vulgaris Treatment Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Acne Vulgaris Treatment Market Size Market Share by Application in 2021

Figure 46. Egypt Acne Vulgaris Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Acne Vulgaris Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Acne Vulgaris Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Acne Vulgaris Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Acne Vulgaris Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Acne Vulgaris Treatment Market Size 2023-2028 ($ Millions)

Figure 52. APAC Acne Vulgaris Treatment Market Size 2023-2028 ($ Millions)

Figure 53. Europe Acne Vulgaris Treatment Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Acne Vulgaris Treatment Market Size 2023-2028 ($ Millions)

Figure 55. United States Acne Vulgaris Treatment Market Size 2023-2028 ($ Millions)

Figure 56. Canada Acne Vulgaris Treatment Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Acne Vulgaris Treatment Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Acne Vulgaris Treatment Market Size 2023-2028 ($ Millions)

Figure 59. China Acne Vulgaris Treatment Market Size 2023-2028 ($ Millions)

Figure 60. Japan Acne Vulgaris Treatment Market Size 2023-2028 ($ Millions)

Figure 61. Korea Acne Vulgaris Treatment Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Acne Vulgaris Treatment Market Size 2023-2028 ($ Millions)

Figure 63. India Acne Vulgaris Treatment Market Size 2023-2028 ($ Millions)

Figure 64. Australia Acne Vulgaris Treatment Market Size 2023-2028 ($ Millions)

Figure 65. Germany Acne Vulgaris Treatment Market Size 2023-2028 ($ Millions)

Figure 66. France Acne Vulgaris Treatment Market Size 2023-2028 ($ Millions)

Figure 67. UK Acne Vulgaris Treatment Market Size 2023-2028 ($ Millions)

Figure 68. Italy Acne Vulgaris Treatment Market Size 2023-2028 ($ Millions)

Figure 69. Russia Acne Vulgaris Treatment Market Size 2023-2028 ($ Millions)

Figure 70. Spain Acne Vulgaris Treatment Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Acne Vulgaris Treatment Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Acne Vulgaris Treatment Market Size 2023-2028 ($ Millions)

Figure 73. Israel Acne Vulgaris Treatment Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Acne Vulgaris Treatment Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Acne Vulgaris Treatment Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450